Published on in Vol 10, No 3 (2022): March
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/35216, first published
.
Journals
- Fang L, Sheng H, Tan Y, Zhang Q. Prevalence of diabetes in the USA from the perspective of demographic characteristics, physical indicators and living habits based on NHANES 2009-2018. Frontiers in Endocrinology 2023;14 View
- Fonseca S, Ribeiro A, Cimini C, Soares T, Delfino-Pereira P, Nogueira L, Moura R, Motta-Santos D, Ribeiro L, Camargos M, Paixão M, Pires M, Batchelor J, Marcolino M. Scale up of implementation of a multidimensional intervention to enhance hypertension and diabetes care at the primary care setting: A protocol for a cluster-randomized study in Brazil. American Heart Journal 2023;262:119 View
- Dunaieva І. Cardiotrophin-1 as a prognostic biomarker of hypertension and a key regulator of cardiac glucose metabolism. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2023;19(2):106 View
- Idris H, Nugraheni W, Rachmawati T, Kusnali A, Yulianti A, Purwatiningsih Y, Nuraini S, Susianti N, Faisal D, Arifin H, Maharani A. How Is Telehealth Currently Being Utilized to Help in Hypertension Management within Primary Healthcare Settings? A Scoping Review. International Journal of Environmental Research and Public Health 2024;21(1):90 View
- Cuevas-Fernández F, Gómez-López O, Dorta-Espiñeira M, Enebral-Quintana A, Cabrera-de León A, Aguirre-Jaime A. Diferencias en la atención a pacientes con diabetes mellitus tipo 2 y con hipertensión arterial durante una epidemia. Un estudio multicéntrico en Atención Primaria. Revista Clínica de Medicina de Familia 2024 View